UnitedHealth Group Incorporated (UNH) Insider Trading

Last 12 months

Insiders sold $945k and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. The last open-market buy by an executive or director was in May 2025.

Net open-market

−$945k

0 buys · 3 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

May 2025

May 16, 2025

Get an email when UNH's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 21	Patrick Hugh Conway Chief Executive Officer, Optum	SoldNo plan	1,169	$390.00	$456k	7.1%	Form 4
Aug 5	Patrick Hugh Conway Chief Executive Officer, Optum	SoldNo plan	500	$410.00	$205k	2.9%	Form 4
Apr 23	Patrick Hugh Conway Chief Executive Officer, Optum	SoldNo plan	800	$355.00	$284k	4.3%	Form 4
Sep 11, 2025	Charles D. Baker Director	SoldNo plan	27	$356.05	$10k	2.1%	Form 4
Jun 10, 2025	Patrick Hugh Conway Chief Executive Officer, Optum	SoldNo plan	589	$305.00	$180k	5.4%	Form 4
May 16, 2025	John F Rex President & CFO	Bought	17,175	$291.12	$5M	8.9%	Form 4
May 16, 2025	Stephen J Hemsley CEO, UHG	Bought	86,700	$288.57	$25M	8.5%	Form 4
May 15, 2025	Kristen Gil Director	Bought	3,700	$271.17	$1M	222%	Form 4
May 14, 2025	Timothy Patrick Flynn Director	Bought	1,533	$320.80	$492k	11%	Form 4
May 14, 2025	John H Noseworthy Director	Bought	300	$312.16	$94k	5.2%	Form 4
Jan 17, 2025	Timothy Patrick Flynn Director	Bought	1,000	$511.58	$512k	8.1%	Form 4
Nov 11, 2024	Erin McSweeney EVP & Chief People Officer	SoldNo plan	701	$626.23	$439k	9.0%	Form 4

Aug 21No plan
Patrick Hugh Conway
Chief Executive Officer, Optum · sold 1,169 at $390.00
$456k
7.1% of stake
Aug 5No plan
Patrick Hugh Conway
Chief Executive Officer, Optum · sold 500 at $410.00
$205k
2.9% of stake
Apr 23No plan
Patrick Hugh Conway
Chief Executive Officer, Optum · sold 800 at $355.00
$284k
4.3% of stake
Sep 11, 2025No plan
Charles D. Baker
Director · sold 27 at $356.05
$10k
2.1% of stake
Jun 10, 2025No plan
Patrick Hugh Conway
Chief Executive Officer, Optum · sold 589 at $305.00
$180k
5.4% of stake
May 16, 2025
John F Rex
President & CFO · bought 17,175 at $291.12
$5M
8.9% of stake
May 16, 2025
Stephen J Hemsley
CEO, UHG · bought 86,700 at $288.57
$25M
8.5% of stake
May 15, 2025
Kristen Gil
Director · bought 3,700 at $271.17
$1M
222% of stake
May 14, 2025
Timothy Patrick Flynn
Director · bought 1,533 at $320.80
$492k
11% of stake
May 14, 2025
John H Noseworthy
Director · bought 300 at $312.16
$94k
5.2% of stake
Jan 17, 2025
Timothy Patrick Flynn
Director · bought 1,000 at $511.58
$512k
8.1% of stake
Nov 11, 2024No plan
Erin McSweeney
EVP & Chief People Officer · sold 701 at $626.23
$439k
9.0% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch UNH, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Hospital & Medical Service Plans

ELVElevance Health, Inc.

CIThe Cigna Group

HUMHumana Inc.

CVSCVS Health Corporation

CNCCentene Corporation

MOHMolina Healthcare Inc.

HCAHCA Healthcare Inc.

Spot a number that looks wrong? Check it in UNH's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing UNH

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.